An Update on Multimodal Pain Management After Total Joint Arthroplasty

Karam J. A., Schwenk E. S., PARVİZİ J.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, cilt.103, sa.17, ss.1652-1662, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 103 Sayı: 17
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2106/jbjs.19.01423
  • Dergi Adı: JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index, SportDiscus, Veterinary Science Database
  • Sayfa Sayıları: ss.1652-1662
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Multimodal analgesia has become the standard of care for total joint arthroplasty as it provides superior analgesia with fewer side effects than opioid-only protocols. Systemic medications, including nonsteroidal anti-inflammatory drugs, acetaminophen, corticosteroids, and gabapentinoids, and local anesthetics via local infiltration analgesia and peripheral nerve blocks, are the foundation of multimodal analgesia in total joint arthroplasty. Ideally, multimodal analgesia should begin preoperatively and continue throughout the perioperative period and beyond discharge. There is insufficient evidence to support the routine use of intravenous acetaminophen or liposomal bupivacaine as part of multimodal analgesia protocols.